Treatment OutcomeFollow-Up StudiesRetrospective StudiesCombined Modality TherapyTime FactorsProspective StudiesOutcome Assessment (Health Care)PrognosisRecurrenceAntineoplastic Combined Chemotherapy ProtocolsRemission InductionLaser TherapyDisease-Free SurvivalNeoplasm Recurrence, LocalSurvival AnalysisTreatment FailureNeoplasm StagingSurvival RateDrug Administration ScheduleTomography, X-Ray ComputedCyclophosphamideVincristinePregnancy OutcomeMethotrexateClinical Trials as TopicPostoperative ComplicationsChemotherapy, AdjuvantRisk FactorsBreast NeoplasmsAntineoplastic AgentsPregnancyAntitubercular AgentsFluorouracilReoperationBrain NeoplasmsDose-Response Relationship, DrugAntibodies, MonoclonalCisplatinDirectly Observed TherapyNeoplasm MetastasisCognitive TherapyOutcome and Process Assessment (Health Care)Magnetic Resonance ImagingCohort StudiesAdenocarcinomaLiver NeoplasmsSeverity of Illness IndexPredictive Value of TestsTuberculosis, PulmonaryPatient ComplianceExtensively Drug-Resistant TuberculosisTuberculosis, Multidrug-ResistantRandomized Controlled Trials as TopicBuprenorphineMultivariate AnalysisKaplan-Meier EstimateOpioid-Related DisordersSubstance-Related DisordersPsychotherapySubstance Abuse Treatment CentersQuality of LifeHIV InfectionsLogistic ModelsAlcoholismInfant, NewbornDrug Therapy, CombinationAge FactorsHospitals, Chronic DiseaseTuberculosisTemperanceRisk AssessmentPatient SatisfactionPsychiatric Status Rating ScalesUnited StatesPatient DropoutsImplosive TherapyCocaine-Related DisordersMethadoneDepressive Disorder, MajorLongitudinal StudiesResidential TreatmentRetreatmentProportional Hazards ModelsRegression AnalysisReproducibility of ResultsAnti-Retroviral AgentsChi-Square DistributionGenotypeCoinfectionIncidenceEthambutolBehavior TherapyMedication AdherenceAnti-HIV AgentsDisease ProgressionResearch DesignPrecursor Cell Lymphoblastic Leukemia-LymphomaAnalysis of VarianceRibavirinPatient Selection